Main > ONCOLOGY (**) > Lung>SCLC>MET > Treatment > ES. P. Lurbinectedin for Inj.

---

ES. P. Lurbinectedin for Inj.'s subsections
(*) AU Approval Date: 2021. 09.14.
(*) CA Approval Date: 2021. 09.
(*) CA Launch Date: 2021. 11.30
(*) SG Approval Date: 2021. 09.22
(*) UAE Approval Date: 2021. 09.01
(*) USA Approval Date: 2020. 06.15.
Company
Company Licensee AU; SG
Company Licensee East & Nord EU; IE
Company Licensee NA
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 2
Patent>UpDate: 2021. 09.14.
Product Web-Site

ES. P. Lurbinectedin for Inj.'s products
This section has no products